Author:
Wei Aria,Taneja Kamil,Diaz Michael J.,Tran Jasmine T.,Forouzandeh Mahtab,Lipner Shari R.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Lotze MT, Dallal RM, Kirkwood JM, Flickinger JC (2001) Cutaneous melanoma. In: VT DeVita, S Hellman, SA Rosenberg, eds. Cancer: Principles and Practice of Oncology. 6th ed. Vol 2. Philadelphia: Lippincott Williams and Wilkins; 2012–2069
2. Rieth JM, Swami U, Mott SL, Zanaty M, Henry MD, Bossler AD, Greenlee JD, Zakharia Y, Vanneste M, Jennings B, Milhem MM (2021) Melanoma brain metastases in the era of targeted therapy and checkpoint inhibitor therapy. Cancers (Basel) 13(7):1489. https://doi.org/10.3390/cancers13071489
3. Cohn-Cedermark G, Månsson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U (1998) Central nervous system metastases of cutaneous malignant melanoma–a population-based study. Acta Oncol 37(5)
4. Zafar FS, Abid R, Ginader T, Powers JG (2021) Rural health disparities in melanoma staging and prognostic outcomes in Iowa. J Am Acad Dermatol 84(6):1727–1730
5. Jain V, Venigalla S, Reddy VK, Lukens JN, Mitchell TC, Shabason JE (2020) Association of insurance status with presentation, treatment, and survival in melanoma in the era of immune checkpoint inhibitors. J Immunother 43(1):8–15